Thursday, March 30, 2017 1:25:57 PM
Recent VTRS News
- Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 • PR Newswire (US) • 04/16/2024 08:30:00 PM
- Viatris Appoints Corinne Le Goff as Chief Commercial Officer • PR Newswire (US) • 04/15/2024 12:00:00 PM
- Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada • PR Newswire (Canada) • 04/15/2024 10:59:00 AM
- Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au Canada • PR Newswire (Canada) • 04/15/2024 10:59:00 AM
- Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States • PR Newswire (US) • 04/01/2024 10:59:00 AM
- Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline • PR Newswire (US) • 03/27/2024 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:29:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:24:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:09:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:54:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:47:44 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:26:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:11:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:39:17 PM
- Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • PR Newswire (US) • 02/28/2024 11:30:00 AM
- Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration • PR Newswire (US) • 02/28/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:00:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 10:18:00 PM
- Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results • PR Newswire (US) • 02/05/2024 11:59:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/30/2024 09:40:59 PM
- Viatris recognised as a Top Employer 2024 in the UK for the second consecutive year • PR Newswire (US) • 01/19/2024 11:56:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:00:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/05/2024 01:28:15 AM
- Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/21/2023 09:05:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM